Neuron-derived orphan receptor-1 modulates cardiac gene expression and exacerbates angiotensin II-induced cardiac hypertrophy. (4th February 2020)
- Record Type:
- Journal Article
- Title:
- Neuron-derived orphan receptor-1 modulates cardiac gene expression and exacerbates angiotensin II-induced cardiac hypertrophy. (4th February 2020)
- Main Title:
- Neuron-derived orphan receptor-1 modulates cardiac gene expression and exacerbates angiotensin II-induced cardiac hypertrophy
- Authors:
- Cañes, Laia
Martí-Pàmies, Ingrid
Ballester-Servera, Carme
Herraiz-Martínez, Adela
Alonso, Judith
Galán, María
Nistal, J. Francisco
Muniesa, Pedro
Osada, Jesús
Hove-Madsen, Leif
Rodríguez, Cristina
Martínez-González, José - Abstract:
- Abstract: Hypertensive cardiac hypertrophy (HCH) is a common cause of heart failure (HF), a major public health problem worldwide. However, the molecular bases of HCH have not been completely elucidated. Neuron-derived orphan receptor-1 (NOR-1) is a nuclear receptor whose role in cardiac remodelling is poorly understood. The aim of the present study was to generate a transgenic mouse over-expressing NOR-1 in the heart (TgNOR-1) and assess the impact of this gain-of-function on HCH. The CAG promoter-driven transgenesis led to viable animals that over-expressed NOR-1 in the heart, mainly in cardiomyocytes and also in cardiofibroblasts. Cardiomyocytes from TgNOR-1 exhibited an enhanced cell surface area and myosin heavy chain 7 ( Myh7 )/ Myh6 expression ratio, and increased cell shortening elicited by electric field stimulation. TgNOR-1 cardiofibroblasts expressed higher levels of myofibroblast markers than wild-type (WT) cells (α 1 skeletal muscle actin ( Acta1 ), transgelin ( Sm22α )) and were more prone to synthesise collagen and migrate. TgNOR-1 mice experienced an age-associated remodelling of the left ventricle (LV). Angiotensin II (AngII) induced the cardiac expression of NOR-1, and NOR-1 transgenesis exacerbated AngII-induced cardiac hypertrophy and fibrosis. This effect was associated with the up-regulation of hypertrophic (brain natriuretic peptide ( Bnp ), Acta1 and Myh7 ) and fibrotic markers (collagen type I α 1 chain ( Col1a1 ), Pai-1 and lysyl oxidase-like 2 (Abstract: Hypertensive cardiac hypertrophy (HCH) is a common cause of heart failure (HF), a major public health problem worldwide. However, the molecular bases of HCH have not been completely elucidated. Neuron-derived orphan receptor-1 (NOR-1) is a nuclear receptor whose role in cardiac remodelling is poorly understood. The aim of the present study was to generate a transgenic mouse over-expressing NOR-1 in the heart (TgNOR-1) and assess the impact of this gain-of-function on HCH. The CAG promoter-driven transgenesis led to viable animals that over-expressed NOR-1 in the heart, mainly in cardiomyocytes and also in cardiofibroblasts. Cardiomyocytes from TgNOR-1 exhibited an enhanced cell surface area and myosin heavy chain 7 ( Myh7 )/ Myh6 expression ratio, and increased cell shortening elicited by electric field stimulation. TgNOR-1 cardiofibroblasts expressed higher levels of myofibroblast markers than wild-type (WT) cells (α 1 skeletal muscle actin ( Acta1 ), transgelin ( Sm22α )) and were more prone to synthesise collagen and migrate. TgNOR-1 mice experienced an age-associated remodelling of the left ventricle (LV). Angiotensin II (AngII) induced the cardiac expression of NOR-1, and NOR-1 transgenesis exacerbated AngII-induced cardiac hypertrophy and fibrosis. This effect was associated with the up-regulation of hypertrophic (brain natriuretic peptide ( Bnp ), Acta1 and Myh7 ) and fibrotic markers (collagen type I α 1 chain ( Col1a1 ), Pai-1 and lysyl oxidase-like 2 ( Loxl2 )). NOR-1 transgenesis up-regulated two key genes involved in cardiac hypertrophy ( Myh7, encoding for β-myosin heavy chain (β-MHC)) and fibrosis ( Loxl2, encoding for the extracellular matrix (ECM) modifying enzyme, Loxl2 ). Interestigly, in transient transfection assays, NOR-1 drove the transcription of Myh7 and Loxl2 promoters. Our findings suggest that NOR-1 is involved in the transcriptional programme leading to HCH. … (more)
- Is Part Of:
- Clinical science. Volume 134:Number 3(2020)
- Journal:
- Clinical science
- Issue:
- Volume 134:Number 3(2020)
- Issue Display:
- Volume 134, Issue 3 (2020)
- Year:
- 2020
- Volume:
- 134
- Issue:
- 3
- Issue Sort Value:
- 2020-0134-0003-0000
- Page Start:
- 359
- Page End:
- 377
- Publication Date:
- 2020-02-04
- Subjects:
- cardiac remodelling -- hypertension -- hypertensive cardiac hypertrophy -- NOR-1
Medicine -- Periodicals
Biochemistry -- Periodicals
616 - Journal URLs:
- https://portlandpress.com/clinsci ↗
- DOI:
- 10.1042/CS20191014 ↗
- Languages:
- English
- ISSNs:
- 0143-5221
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD Digital store
- Ingest File:
- 12941.xml